Niagen Bioscience, Inc. (NAGE)

Profile

Full Name

Niagen Bioscience, Inc.

Ticker

NASDAQ: NAGE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 24, 2015

Indexes

Not included

Website

https://www.niagenbioscience.com

Employees

104

Key Details

Price

$9.77(+1.45%)

Market cap

$779.19M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$99.60M(+19.18% YoY)

Annual EPS

$0.11(+257.14% YoY)

PE ratio

46.52

Next earnings date

Oct 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.77
    NAGE price is $9.77

    30-Day Relative Volume

    0.47
    NAGE 30-day relative volume is 0.47

    Price Performance

    Price Most recent change

    +1.45%
    NAGE price was up +1.45% on Aug 21, 2025

    Price YTD change

    +83.99%
    NAGE price is up +83.99% since January 1st

    Price 1-year change

    +183.19%
    NAGE price is up +183.19% year-on-year

    Price 3-year change

    +526.28%
    NAGE price is up +526.28% over the past 3 years

    Price Range

    Price All-time high

    $23.66
    NAGE price is currently -58.71% below its historical high of $23.66

    Price 3-year low

    $1.15
    NAGE price is currently +749.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $779.19M
    NAGE market capitalization is $779.19 million

    Market cap 3-year change

    +630.84%
    NAGE market capitalization is up +630.84% over the past 3 years

    Market cap All-time high

    $1.24B
    NAGE market capitalization is currently -37.21% below its historical high of $1.24 billion

    Market cap sector rank

    70.46%
    NAGE market capitalization is higher than 70.46% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.03%
    NAGE shares outstanding is up +5.03% year-on-year

    Shares Outstanding 3-Year Change

    +16.7%
    NAGE shares outstanding is up +16.7% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.78
    NAGE beta is 1.78

    200-day SMA

    $8.22
    NAGE price is currently +18.89% above its 200-day simple moving average

    50-day SMA

    $11.29
    NAGE price is currently -13.43% below its 50-day simple moving average

    RSI

    45.58
    NAGE 14-day relative strength index is 45.58

    Volume

    0.47
    NAGE 30-day relative volume is 0.47

    ATR

    $0.54
    NAGE average true range is $0.54

    10-day Historical Volatility

    46.44%
    NAGE 10-day historical volatility is 46.44%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $99.60M
    NAGE annual revenue is $99.60 million

    Revenue Analysts estimate

    $126.00M
    NAGE annual revenue is currently -20.96% lower than the consensus analysts' forecast

    Revenue 1-year change

    +19.18%
    NAGE annual revenue is up +19.18% year-on-year

    Revenue Sector rank

    68.43%
    NAGE annual revenue is higher than 68.43% of companies in Healthcare sector

    EPS

    EPS

    $0.11
    NAGE annual earnings per share is $0.11

    EPS Analysts estimate

    $0.14
    NAGE annual earnings per share is currently -21.43% lower than the consensus analysts' forecast

    EPS 1-year change

    +257.14%
    NAGE annual earnings per share is up +257.14% year-on-year

    EPS Sector rank

    84.47%
    NAGE annual earnings per share is higher than 84.47% of companies in Healthcare sector

    Profit

    Gross profit

    $61.59M
    NAGE annual gross profit is $61.59 million

    Gross margin

    61.84%
    NAGE annual gross profit margin is 61.84%

    Operating profit

    $7.73M
    NAGE annual operating income is $7.73 million

    Operating margin

    7.76%
    NAGE annual operating profit margin is 7.76%

    Net income

    $8.55M
    NAGE annual net profit is $8.55 million

    Net margin

    8.58%
    NAGE annual net profit margin is 8.58%

    Expenses

    Total expenses

    $91.05M
    NAGE annual total expenses is $91.05 million

    Operating expenses

    $53.86M
    NAGE annual total operating expenses is $53.86 million

    Cost of goods sold

    $38.01M
    NAGE annual cost of goods sold is $38.01 million

    Selling, general & administrative expenses

    $0.00
    NAGE annual SGA is $0.00

    Depreciation and amortization

    $1.48M
    NAGE annual depreciation & amortization is $1.48 million

    Interest expense

    $0.00
    NAGE annual interest expense is $0.00

    Income tax

    $305.00K
    NAGE annual income tax is $305.00 thousand

    EBIT & EBITDA

    EBIT

    $7.73M
    NAGE annual earnings before interest & taxes is $7.73 million

    EBITDA

    $9.21M
    NAGE annual EBITDA is $9.21 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $68.28M
    NAGE annual total assets is $68.28 million

    Non current assets

    $4.18M
    NAGE annual long term assets is $4.18 million

    Current assets

    $64.10M
    NAGE annual total current assets is $64.10 million

    Cash and cash equivalents

    $44.66M
    NAGE annual cash & cash equivalents is $44.66 million

    Accounts receivable

    $7.77M
    NAGE annual accounts receivable is $7.77 million

    Inventory

    $9.19M
    NAGE annual inventory is $9.19 million

    Liabilities

    Total liabilities

    $22.18M
    NAGE annual total liabilities is $22.18 million

    Long term liabilities

    $4.24M
    NAGE annual total long term liabilities is $4.24 million

    Current liabilities

    $17.95M
    NAGE annual total current liabilities is $17.95 million

    Accounts payable

    $8.53M
    NAGE annual accounts payable is $8.53 million

    Debt

    Total debt

    $2.65M
    NAGE annual total debt is $2.65 million

    Total debt 1-year change

    -19.1%
    NAGE annual total debt is down -19.1% year-on-year

    Long term debt

    $1.66M
    NAGE annual long term debt is $1.66 million

    Short term debt

    $994.00K
    NAGE annual short term debt is $994.00 thousand

    Equity & Capital

    Shareholders equity

    $46.09M
    NAGE annual stockholders equity is $46.09 million

    Book value

    $46.09M
    NAGE annual book value is $46.09 million

    Retained earnings

    -$181.91M
    NAGE annual retained earnings is -$181.91 million

    Working capital

    $46.15M
    NAGE annual working capital is $46.15 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $12.06M
    NAGE annual cash flow from operations is $12.06 million

    Cash from operations 1-year change

    +71.22%
    NAGE annual cash flow from operations is up +71.22% year-on-year

    Cash from investing

    -$143.00K
    NAGE annual cash flow from investing activities is -$143.00 thousand

    Cash from investing 1-year change

    0%
    NAGE annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $5.42M
    NAGE annual cash flow from financing activities is $5.42 million

    Cash from financing 1-year change

    +36240%
    NAGE annual cash flow from financing activities is up +36240% year-on-year

    CAPEX

    CAPEX

    $163.00K
    NAGE annual capital expenditures is $163.00 thousand

    CAPEX 1-year change

    +10.14%
    NAGE annual capital expenditures is up +10.14% year-on-year

    Free Cash Flow

    Free cash flow

    $11.89M
    NAGE annual free cash flow is $11.89 million

    Free cash flow 1-year change

    +72.53%
    NAGE annual free cash flow is up +72.53% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    61.84%
    NAGE annual gross profit margin is 61.84%

    Operating margin

    7.76%
    NAGE annual operating profit margin is 7.76%

    Net margin

    8.58%
    NAGE annual net profit margin is 8.58%

    ROA & ROE

    ROA

    13.88%
    NAGE annual return on assets is 13.88%

    ROE

    22.94%
    NAGE annual return on equity is 22.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    46.52
    NAGE price to earnings ratio is 46.52

    PE ratio Sector rank

    76.89%
    NAGE price to earnings ratio is higher than 76.89% of companies in Healthcare sector

    PB Ratio

    PB ratio

    12.14
    NAGE price to book ratio is 12.14

    PB ratio Sector rank

    91.42%
    NAGE price to book ratio is higher than 91.42% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.70
    NAGE price to sales ratio is 6.70

    PS ratio Sector rank

    65.23%
    NAGE price to sales ratio is higher than 65.23% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $722.00M
    NAGE enterprise value is $722.00 million

    Enterprise value Sector rank

    71.11%
    NAGE enterprise value is higher than 71.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    38.03
    NAGE EV/EBITDA is 38.03

    EV/EBITDA Sector rank

    95.37%
    NAGE EV/EBITDA is higher than 95.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.57
    NAGE annual current ratio is 3.57

    Quick ratio

    3.06
    NAGE annual quick ratio is 3.06

    Leverage

    Debt to equity

    0.06
    NAGE annual debt to equity ratio is 0.06

    Interest coverage ratio

    -
    NAGE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    NAGE piotroski f-score is 6

    Altman Z-Score

    19.99
    NAGE altman z-score is 19.99

    Analyst ratings

    Recent major analysts updates

    Aug 11, 25 HC Wainwright & Co.
    Buy
    Jun 10, 25 Canaccord Genuity
    Buy
    Jun 6, 25 Roth Capital
    Buy
    May 27, 25 Canaccord Genuity
    Buy
    Apr 8, 25 HC Wainwright & Co.
    Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 17, 25 HC Wainwright & Co.
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 5, 25 Ladenburg Thalmann
    Buy
    Nov 6, 24 Roth MKM
    Buy

    Institutional Ownership

    Screeners with NAGE included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    High revenue growth stocks
    Healthcare sector
    • What is the ticker symbol for Niagen Bioscience, Inc.?
    • Does Niagen Bioscience, Inc. pay dividends?
    • What sector is Niagen Bioscience, Inc. in?
    • What industry is Niagen Bioscience, Inc. in?
    • What country is Niagen Bioscience, Inc. based in?
    • When did Niagen Bioscience, Inc. go public?
    • Is Niagen Bioscience, Inc. in the S&P 500?
    • Is Niagen Bioscience, Inc. in the NASDAQ 100?
    • Is Niagen Bioscience, Inc. in the Dow Jones?
    • When was Niagen Bioscience, Inc.'s last earnings report?
    • When does Niagen Bioscience, Inc. report earnings?

    What is the ticker symbol for Niagen Bioscience, Inc.?

    The ticker symbol for Niagen Bioscience, Inc. is NASDAQ:NAGE

    Does Niagen Bioscience, Inc. pay dividends?

    No, Niagen Bioscience, Inc. does not pay dividends

    What sector is Niagen Bioscience, Inc. in?

    Niagen Bioscience, Inc. is in the Healthcare sector

    What industry is Niagen Bioscience, Inc. in?

    Niagen Bioscience, Inc. is in the Biotechnology industry

    What country is Niagen Bioscience, Inc. based in?

    Niagen Bioscience, Inc. is headquartered in United States

    When did Niagen Bioscience, Inc. go public?

    Niagen Bioscience, Inc.'s initial public offering (IPO) was on June 24, 2015

    Is Niagen Bioscience, Inc. in the S&P 500?

    No, Niagen Bioscience, Inc. is not included in the S&P 500 index

    Is Niagen Bioscience, Inc. in the NASDAQ 100?

    No, Niagen Bioscience, Inc. is not included in the NASDAQ 100 index

    Is Niagen Bioscience, Inc. in the Dow Jones?

    No, Niagen Bioscience, Inc. is not included in the Dow Jones index

    When was Niagen Bioscience, Inc.'s last earnings report?

    Niagen Bioscience, Inc.'s most recent earnings report was on August 6, 2025

    When does Niagen Bioscience, Inc. report earnings?

    The next expected earnings date for Niagen Bioscience, Inc. is October 29, 2025
    On this page